Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharron H Francis

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Circulation Research|November 13, 2010
The role of cGMP-dependent protein kinase in controlling cardiomyocyte cGMPSharron H Francis
Expert Opinion on Drug Metabolism & Toxicology|August 23, 2006
Sildenafil: efficacy, safety, tolerability and mechanism of action in treating erectile dysfunctionSharron H Francis, Jackie D Corbin
The Urologic Clinics of North America|November 18, 2005
Phosphodiesterase-5 inhibition: the molecular biology of erectile function and dysfunctionSharron H Francis, Jackie D Corbin
Cellular Signalling|May 31, 2011
Conformational conversion of PDE5 by incubation with sildenafil or metal ion is accompanied by stimulation of allosteric cGMP bindingJackie D Corbin, Sharron H Francis
Current Opinion in Pharmacology|September 20, 2011
PDE5 inhibitors: targeting erectile dysfunction in diabeticsSharron H Francis, Jackie D Corbin
Journal of Andrology|October 29, 2003
Molecular biology and pharmacology of PDE-5-inhibitor therapy for erectile dysfunctionJackie D Corbin, Sharron H Francis
Current Urology Reports|November 19, 2003
Molecular mechanisms and pharmacokinetics of phosphodiesterase-5 antagonistsSharron H Francis, Jackie D Corbin
The Journal of Biological Chemistry|January 13, 2006
Phosphodiesterase-5 Gln817 is critical for cGMP, vardenafil, or sildenafil affinity: its orientation impacts cGMP but not cAMP affinityRoya Zoraghi, Jackie D Corbin, Sharron H Francis
Cellular Signalling|August 12, 2009
Allosteric-site and catalytic-site ligand effects on PDE5 functions are associated with distinct changes in physical form of the enzymeJackie D Corbin, Roya Zoraghi, Sharron H Francis
Molecular Pharmacology|January 27, 2004
Properties and functions of GAF domains in cyclic nucleotide phosphodiesterases and other proteinsRoya Zoraghi, Jackie D Corbin, Sharron H Francis
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Circulation Research|November 13, 2010
The role of cGMP-dependent protein kinase in controlling cardiomyocyte cGMPSharron H Francis
Expert Opinion on Drug Metabolism & Toxicology|August 23, 2006
Sildenafil: efficacy, safety, tolerability and mechanism of action in treating erectile dysfunctionSharron H Francis, Jackie D Corbin
The Urologic Clinics of North America|November 18, 2005
Phosphodiesterase-5 inhibition: the molecular biology of erectile function and dysfunctionSharron H Francis, Jackie D Corbin
Cellular Signalling|May 31, 2011
Conformational conversion of PDE5 by incubation with sildenafil or metal ion is accompanied by stimulation of allosteric cGMP bindingJackie D Corbin, Sharron H Francis
Current Opinion in Pharmacology|September 20, 2011
PDE5 inhibitors: targeting erectile dysfunction in diabeticsSharron H Francis, Jackie D Corbin
Journal of Andrology|October 29, 2003
Molecular biology and pharmacology of PDE-5-inhibitor therapy for erectile dysfunctionJackie D Corbin, Sharron H Francis
Current Urology Reports|November 19, 2003
Molecular mechanisms and pharmacokinetics of phosphodiesterase-5 antagonistsSharron H Francis, Jackie D Corbin
The Journal of Biological Chemistry|January 13, 2006
Phosphodiesterase-5 Gln817 is critical for cGMP, vardenafil, or sildenafil affinity: its orientation impacts cGMP but not cAMP affinityRoya Zoraghi, Jackie D Corbin, Sharron H Francis
Cellular Signalling|August 12, 2009
Allosteric-site and catalytic-site ligand effects on PDE5 functions are associated with distinct changes in physical form of the enzymeJackie D Corbin, Roya Zoraghi, Sharron H Francis
Molecular Pharmacology|January 27, 2004
Properties and functions of GAF domains in cyclic nucleotide phosphodiesterases and other proteinsRoya Zoraghi, Jackie D Corbin, Sharron H Francis
Pageof 6